Shandong Jincheng Pharmaceutical Group Co., Ltd

Shenzhen Stock Exchange 300233.SZ

Shandong Jincheng Pharmaceutical Group Co., Ltd Shareholders' Equity for the year ending December 31, 2023: USD 523.14 M

Shandong Jincheng Pharmaceutical Group Co., Ltd Shareholders' Equity is USD 523.14 M for the year ending December 31, 2023, a 0.07% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Shandong Jincheng Pharmaceutical Group Co., Ltd Shareholders' Equity for the year ending December 31, 2022 was USD 522.75 M, a -2.15% change year over year.
  • Shandong Jincheng Pharmaceutical Group Co., Ltd Shareholders' Equity for the year ending December 31, 2021 was USD 534.22 M, a 1.43% change year over year.
  • Shandong Jincheng Pharmaceutical Group Co., Ltd Shareholders' Equity for the year ending December 31, 2020 was USD 526.70 M, a -9.75% change year over year.
  • Shandong Jincheng Pharmaceutical Group Co., Ltd Shareholders' Equity for the year ending December 31, 2019 was USD 583.61 M, a 0.11% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
SV Wall Street
Shenzhen Stock Exchange: 300233.SZ

Shandong Jincheng Pharmaceutical Group Co., Ltd

CEO Mr. Jiaquan Li
IPO Date June 22, 2011
Location China
Headquarters No.1 Shuangshan Road
Employees 3,806
Sector Healthcare
Industries
Pharmaceuticals Baby & Childcare Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Fertilizers Personal Care Pet Food
Description

Shandong Jincheng Pharmaceutical Group Co., Ltd, together with its subsidiaries, researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers active pharmaceutical ingredients, biopharmaceuticals, medical intermediates, fine chemicals, finished dosages, and pharmaceutical products. It also provides animal nutrition and health care, as well as CMO and CDMO services. The company was founded in 2004 and is based in Zibo, China.

StockViz Staff

February 2, 2025

Any question? Send us an email